CREB3L1 mRNA as lineage-associated biomarker in MPN
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-06-02 — Genomic insights transform diagnosis, prognosis, and therapy in BCR::ABL1-negative myeloproliferative neoplasms.: Review nominates platelet-derived CREB3L1 mRNA expression as a novel functional biomarker concept that could complement genotype-based classification and support mechanism-aligned molecular monitoring in MPN. (novelty: 3)